Microbiota, Sarcopenia, and Hepatic Encephalopathy Change in Cirrhotic Patients Before and After Rehabilitation
Hepatic Encephalopathy
About this trial
This is an interventional treatment trial for Hepatic Encephalopathy focused on measuring Liver cirrhosis, Hepatic encephalopathy, Psychometric test, Sarcopenia, Fecal microbiota
Eligibility Criteria
Inclusion Criteria: Patients with liver cirrhosis Exclusion Criteria: unstable vital sign such as shock, coma or intubation status Non-curative hepatocellular carcinoma (cannot receive operation, radiofrequency ablation, liver transplantation,etc Un-curative malignancies Poor-controlled diabetes mellitus (HbA1C≧8) Active alcoholism (male alcohol ≧40g/day, or ≧140g/week; female ≧ 30g/day, or ≧70g/week Psychiatric comorbidities Neurologic comorbidities like Alzheimer's, Parkinson's, stroke with neurological deficit Unable to speak Bed-ridden status Post- Liver transplantation.
Sites / Locations
- Chang Gung Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Rehabilitation Training
No-Rehabilitation Training
Rehabilitation Training is provided to patients with Liver Cirrhosis combined with sarcopenia.
No extra training is provided to patients with Liver Cirrhosis combined with sarcopenia.